Celtarys Research develops fluorescent probes that replace radioactive tracers in scientific research and diagnostics, utilizing fluorescence-based methods for precise and reliable results. This technology mitigates health and safety risks associated with radioactivity while enhancing the efficiency of drug discovery processes.
Funding
$770K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods in drug discovery and scientific research often rely on radioactive tracers, which pose health and safety risks, require specialized handling and disposal procedures, and can be less efficient for high-throughput screening and lead optimization. These limitations can slow down research processes and increase costs.
Solution
Celtarys Research develops and commercializes innovative fluorescent ligands and chemical tools that replace radioactive tracers in drug discovery and scientific research. Their technology enables fluorescence-based methods for precise, reliable, and safer results. Celtarys's fluorescent ligands are designed to improve the performance of high-throughput screening (HTS) and lead optimization assays, reducing costs and accelerating research. The company's proprietary technology allows for the development of tailor-suited fluorescent ligands for various druggable targets, including GPCRs, E3 ligases, and intracellular receptors.
Target Audience
Celtarys Research primarily serves pharmaceutical and biotech companies, as well as academic research groups involved in drug discovery and chemical biology.
Features
- Fluorescent ligands designed as direct replacements for radioactive tracers in binding assays.
- GPCR fluorescent ligands with high potency (< 100 nM) and selectivity (> 100 times).
- Stable fluorophores that maintain affinity and offer diverse photo-physical properties.
- Ligands suitable for various applications, including competitive binding assays and microscopy.
- Custom development services for creating new fluorescent ligands tailored to specific targets.
- Environment-respectful, flexible, and convergent synthetic chemical methodologies for efficient ligand development.